Leveraging Healthy Volunteers for Anticancer Drug Clinical Pharmacology Studies: A Review Article Featuring Futibatinib as an Example

Aernout D. van Haarst, Sabina Paglialunga, Ziv Machnes, Ikuo Yamamiya, Nanae Hangai, Aram Oganesian

Open source

DOI
10.1111/cts.70711
Published
2026-09
Container
Clinical and Translational Science
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/cts.70711,
  title = {Leveraging Healthy Volunteers for Anticancer Drug Clinical Pharmacology Studies: A Review Article Featuring Futibatinib as an Example},
  author = {Aernout D. van Haarst and Sabina Paglialunga and Ziv Machnes and Ikuo Yamamiya and Nanae Hangai and Aram Oganesian},
  year = {2026},
  journal = {Clinical and Translational Science},
  doi = {10.1111/cts.70711},
  url = {https://doi.org/10.1111/cts.70711}
}

RIS

TY  - JOUR
TI  - Leveraging Healthy Volunteers for Anticancer Drug Clinical Pharmacology Studies: A Review Article Featuring Futibatinib as an Example
AU  - Aernout D. van Haarst
AU  - Sabina Paglialunga
AU  - Ziv Machnes
AU  - Ikuo Yamamiya
AU  - Nanae Hangai
AU  - Aram Oganesian
PY  - 2026
JO  - Clinical and Translational Science
DO  - 10.1111/cts.70711
UR  - https://doi.org/10.1111/cts.70711
ER  - 

APA

Haarst, A. D. V., Paglialunga, S., Machnes, Z., Yamamiya, I., Hangai, N., & Oganesian, A. (2026). Leveraging Healthy Volunteers for Anticancer Drug Clinical Pharmacology Studies: A Review Article Featuring Futibatinib as an Example. Clinical and Translational Science. https://doi.org/10.1111/cts.70711

Source records